- Home
- Accentrix Livi 0.5 mg Injection
Accentrix Livi 0.5 mg Injection Substitute
Accentrix Livi 0.5 mg Injection Substitute
Verified Ingredients and Effects
Composition:
RANIBIZUMAB-0.5MG
Uses:
Accentrix Livi 0.5 mg Injection is used in the treatment of Neovascular (wet) age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR), and choroidal neovascularization (CNV). Also used in premature babies to treat retinopathy of prematurity (ROP).
Medicinal Benefits:
Accentrix Livi 0.5 mg Injection belongs to the group of medicines called anti-neovascularisation agents used to treat eye diseases causing vision impairment, such as neovascular (wet) age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR), and choroidal neovascularization (CNV). Accentrix Livi 0.5 mg Injection contains Ranibizumab, a vascular endothelial growth factor A (VEGF-A) antagonist, which binds to VEGF-A (a protein which causes abnormal blood vessel growth and swelling, leading to vision impairment) present in the eyes, blocks its action and prevents abnormal growth and swelling. It helps stabilise and improve your vision. This medicine may also be indicated in preterm infants for the treatment of retinopathy of prematurity (ROP).
FAQs
Accentrix Livi 0.5 mg Injection is used to treat Neovascular (wet) age-related macular degeneration (AMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME), proliferative diabetic retinopathy (PDR), and choroidal neovascularization (CNV). Also used in premature babies to treat retinopathy of prematurity (ROP).
Accentrix Livi 0.5 mg Injection works by stopping abnormal blood vessel growth and leakage in the eyes that may cause vision loss.
Accentrix Livi 0.5 mg Injection may affect fertility. Fertility problems may interfere with the ability to get pregnant or father a child. Consult the doctor if you have any concerns.
Accentrix Livi 0.5 mg Injection can be used in the elderly aged 65 years or older if prescribed by the doctor. However, talk to the doctor if you have any concerns.
Accentrix Livi 0.5 mg Injection should not be used by individuals who are allergic to any of its active ingredients and those who have an eye infection, eye inflammation, or severe inflammation within the eye. Always consult your healthcare provider before using this medication.
The duration of treatment with Accentrix Livi 0.5 mg Injection depends on the condition being treated and your response to the medication. Your healthcare provider will determine the appropriate length of treatment.
After taking Accentrix Livi 0.5 mg Injection, inform your doctor if you experience eye pain, discomfort, redness, blurred vision, or increased sensitivity to light. Monitor for signs of infection or retinal detachment, and contact your doctor if these occur. Your doctor may also check eye pressure, as it can temporarily rise. Additionally, inform your doctor if you have a history of eye conditions or stroke-related symptoms.
Accentrix Livi 0.5 mg Injection causes side effects such as inflammation of eye, retinal bleeding (bleeding in the back of eye), eye pain, a bloodshot eye, small particles or spots in the vision, eye irritation, dry eye, redness or itching in eye, and increased eye pressure. However, please contact a doctor if these side effects persist for longer durations.